MENU
KZIA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Kazia Therapeutics (KZIA) Ownership - Who owns Kazia Therapeutics?
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
300 Barangaroo Avenue
Phone
+61 294724101
Employees
16
Web
https://www.kaziatherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.98M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
N/A
Revenue
2.31M
Risk (Beta)
1.71
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
2.81 USD as % of share price
Fundamentals
KZIA
Capitalization
3.98M
P/E Ratio
N/A
Risk (Beta)
1.71
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
2.81%
Revenue
2.31M
ROE
N/A
Book Value
N/A
P/B Ratio
4.47
Cash Flow
N/A
Earnings
-50.8
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
N/A
Current Ratio
0.24
Current Revenue Per Employee
42613.86
Dividends Per Share - Security
N/A
EBITDA
-26.77M
Float
N/A
Float - Current
N/A
Gross Income Margin
73.26
Revenue To Assets
-107.83
Shares Held By Institutions
568K
Shares Outstanding - Current
1.12M
Total Liabilities
N/A
Total Volume MTD
N/A
Value
N/A
Gain YTD
-59.763
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company, which engages in the business of pharmaceutical research and development
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
300 Barangaroo Avenue
Phone
+61 294724101
Employees
16
Web
https://www.kaziatherapeutics.com